Littlewood v. Novartis Pharmaceuticals Corp
Plaintiff: Lauri Littlewood
Defendant: Novartis Pharmaceuticals Corporation and Novartis Pharmaceuticals Corp
Case Number: 1:2021cv02559
Filed: September 21, 2021
Court: US District Court for the District of Colorado
Presiding Judge: Christine M Arguello
Referring Judge: S Kato Crews
2 Judge: Susan Prose
3 Judge: Susan B Prose
Nature of Suit: Civil Rights: Jobs
Cause of Action: 29 U.S.C. § 203 Equal Pay Act
Jury Demanded By: Plaintiff
Docket Report

This docket was last retrieved on November 7, 2023. A more recent docket listing may be available from PACER.

Date Filed Document Text
November 7, 2023 Filing 81 REPLY to Response to #78 MOTION for Sanctions Opposition filed by Defendant Novartis Pharmaceuticals Corp. (Attachments: #1 Exhibit 1-Aug. 30, 2023 Email)(McIntyre, Michael)
October 24, 2023 Opinion or Order Filing 80 ORDER by Magistrate Judge Susan Prose on 10/24/2023, finding as moot #78 Motion for Sanctions. Although filed as a motion, this document is Plaintiff's opposition to Defendant's motion (ECF No. 73) for sanctions, and the court will consider it as such. Text Only Entry (sbplc1)
October 24, 2023 Filing 79 MEMORANDUM regarding #78 MOTION for Sanctions Opposition filed by Lauri Littlewood. Motion referred to Magistrate Judge Susan Prose by Senior Judge Christine M. Arguello on 10/24/2023. (cmasec)
October 24, 2023 Filing 78 MOTION for Sanctions Opposition by Plaintiff Lauri Littlewood. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Proposed Order (PDF Only))(Harrington, John)
October 2, 2023 Opinion or Order Filing 77 MINUTE ORDER by Magistrate Judge Susan Prose on 10/2/2023, GRANTING #75 Unopposed MOTION for Extension of Time to File Response/Reply as to #73 MOTION for Sanctions. Plaintiff's response to the motion for sanctions is due by 10/24/2023. Text Only Entry (sbplc1)
September 29, 2023 Filing 76 MEMORANDUM regarding #75 Unopposed MOTION for Extension of Time to File Response/Reply as to #73 MOTION for Sanctions filed by Lauri Littlewood. Motion referred to Magistrate Judge Susan Prose by Senior Judge Christine M. Arguello on 9/29/2023. Text Only Entry (cmasec)
September 27, 2023 Filing 75 Unopposed MOTION for Extension of Time to File Response/Reply as to #73 MOTION for Sanctions by Plaintiff Lauri Littlewood. (Attachments: #1 Proposed Order (PDF Only))(Harrington, John)
September 19, 2023 Filing 74 MEMORANDUM regarding #73 MOTION for Sanctions filed by Novartis Pharmaceuticals Corp. Motions referred to Magistrate Judge Susan Prose by Senior Judge Christine M. Arguello on 9/19/2023. Text Only Entry (cmasec)
September 19, 2023 Filing 73 MOTION for Sanctions by Defendant Novartis Pharmaceuticals Corp. (Attachments: #1 Exhibit 1-OSHA Complaint, #2 Exhibit 2-EEOC Charge, #3 Exhibit 3-Discovery Responses, #4 Exhibit 4-L. Littlewood Dep. Tr., #5 Exhibit 5-Letter on Spoliation, #6 Exhibit 6-Email Chain on Spoliation, #7 Exhibit 7-First Interhack Report, #8 Exhibit 8-Second Interhack Report, #9 Exhibit 9-J. Gatrell Dep. Excerpt)(McIntyre, Michael)
August 29, 2023 Filing 72 COURTROOM MINUTES for Telephonic Discovery Hearing held on 8/29/2023 before Magistrate Judge Susan Prose. ORDERED: Plaintiff shall provide the information Defendant is seeking in relation to the iCloud archive as to her iPhone, as stated on the record and for the additional reasons articulated in the Amended Order [Docket No. 70], on or before September 5, 2023. The joint oral motion for extension of the dispositive motion deadline is GRANTED. The dispositive motions deadline is extended to December 5, 2023. FTR: SBP C205. (sgrim)
August 28, 2023 Opinion or Order Filing 71 MINUTE ORDER by Magistrate Judge Susan Prose on 8/28/2023. On the parties' request, a 15-minute telephone discovery conference is set for 8/29/2023, at 11:00 AM in Courtroom C205 before Magistrate Judge Susan Prose. The parties shall attend by calling 571-353-2301, Guest meeting ID- 868150043. All attendees shall please mute their phone when not speaking and not use speaker phone. Text Only Entry (splc1)
July 13, 2023 Opinion or Order Filing 70 AMENDED ORDER by Magistrate Judge Susan Prose on 7/13/2023, amending ECF No. #69 Order. See attached order for particulars. Fact discovery deadline remains 9/5/2023. Dispositive Motions deadline remains 10/5/2023. (splc1)
July 7, 2023 Opinion or Order Filing 69 ORDER by Magistrate Judge Susan Prose on 7/7/2023. Defendant's Motion to Compel, ECF No. 60, is GRANTED IN PART. See attached order for particulars. Fact Discovery Deadline is 9/5/2023. Dispositive Motions due by 10/5/2023. (splc1)
June 8, 2023 Filing 68 MINUTE ENTRY for proceedings held before Magistrate Judge Susan Prose: Discovery Hearing held on 6/8/2023. FTR: C205. (cpomm, )
June 2, 2023 Opinion or Order Filing 67 MINUTE ORDER by Magistrate Judge Susan Prose on 6/2/2023. Regarding the discovery dispute submitted in #65 Brief filed by Defendant Novartis Pharmaceuticals Corp, #63 Brief, filed by Plaintiff Lauri Littlewood, and #60 Brief, filed by Novartis, a 30-minute Telephone Discovery Conference is set for 6/8/2023, at 01:30 PM in Courtroom C205 before Magistrate Judge Susan Prose. The parties shall attend by calling 571-353-2301, Guest meeting ID- 868150043. All attendees shall please mute their phone when not speaking and not use speaker phone. If counsel have calendar conflicts with this date and time, they shall confer and contact chambers at prose_chambers@cod.uscourts.gov at least two business days before the conference to reset. If the parties have resolved this discovery dispute, they shall file a notice as soon as possible. Text Only Entry (splc1)
May 3, 2023 Opinion or Order Filing 66 REASSIGNING MAGISTRATE JUDGE. This action is reassigned to Magistrate Judge Susan Prose upon her appointment. All future pleadings should reference Magistrate Judge Prose at the end of the civil action number (such as 21-cv-02559-CMA-SP). Unless otherwise ordered, the dates and times for all previously scheduled matters will be maintained and will now be handled by Magistrate Judge Prose in Courtroom C-205. Her chambers are located in Room C-254 of the Byron G. Rogers Courthouse. Her telephone number is 303-335-2722. (Text only entry) (alave, )
March 10, 2023 Filing 65 BRIEF re #60 Brief, (Reply in Support) by Defendant Novartis Pharmaceuticals Corp. (McIntyre, Michael)
February 27, 2023 Opinion or Order Filing 64 ORDER granting #61 Motion to Amend/Correct/Modify. Following the resolution of the pending discovery dispute, the parties may have 60 days to complete discovery. Dispositive motions will be due 30 days following the close of discovery. By Magistrate Judge S. Kato Crews on 2/27/2023. Text Only Entry (skclc1)
February 24, 2023 Filing 63 BRIEF re #60 Brief, Opposition to Motion to Compel by Plaintiff Lauri Littlewood. (Attachments: #1 Proposed Order (PDF Only) Proposed Order, #2 Exhibit Exhibit 1, #3 Exhibit Exhibit 2, #4 Exhibit Exhibit 3, #5 Exhibit Exhibit 4, #6 Exhibit Exhibit 5, #7 Exhibit Exhibit 6, #8 Exhibit Exhibit 7)(Harrington, John)
February 7, 2023 Opinion or Order Filing 62 MEMORANDUM regarding #61 Unopposed MOTION to Amend/Correct/Modify 59 Minute Order, filed by Novartis Pharmaceuticals Corp. Motion referred to Magistrate Judge S. Kato Crews by Senior Judge Christine M. Arguello on 2/7/2023. Text Only Entry (cmasec)
February 7, 2023 Filing 61 Unopposed MOTION to Amend/Correct/Modify 59 Minute Order,,,,,, by Defendant Novartis Pharmaceuticals Corp. (Attachments: #1 Proposed Order (PDF Only))(McIntyre, Michael)
February 3, 2023 Filing 60 BRIEF (Discovery Brief on Motion to Compel) by Defendant Novartis Pharmaceuticals Corp. (Attachments: #1 Exhibit 1-OSHA Complaint, #2 Exhibit 2-EEOC Charge, #3 Exhibit 3-Discovery Responses, #4 Exhibit 4-L. Littlewood Dep. Tr., #5 Exhibit 5-Letter on Spoliation, #6 Exhibit 6-Email Chain on Spoliation, #7 Exhibit 7-J. Gatrelle Dep. Tr. Excerpts, #8 Proposed Order (PDF Only) Proposed order)(McIntyre, Michael)
November 10, 2022 Opinion or Order Filing 59 MINUTE ORDER: The parties contact this Court's chambers pursuant to its practice standards regarding discovery disputes and to address developments necessitating adjustments to the Scheduling Order. Based on that phone call, and for good cause, the Court amends the Scheduling Order deadlines as follows: Deadline for written discovery is 1/30/2023; Discovery closes on 2/28/2023, Plaintiff is limited to one 30(b)(6) deposition; and Dispositive Motions are due by 3/28/2023. In addition, the Final Pretrial Conference is VACATED. Within 72 hours of receiving an Order on any dispositive motion, the parties shall contact the Court to reset the Conference. If no dispositive motions are filed, the parties shall contact the Court on or before 4/3/2023, to select a date for the Final Pretrial Conference. With respect to the pending discovery dispute, if (after further conferral) the parties are unable to resolve the dispute, they are given leave to file a Joint Discovery Dispute Report. The report must address and include headings for the following sections: (1) names of attorneys who participated in the discovery conferral; (2) date conferral conference(s) was held and amount of time the parties conferred; (3) the matters that were resolved by agreement; (4) specific matters that remain to be heard and determined; and (5) detailed explanation of the reasons why agreement could not be reached, with the parties' respective arguments and authorities. There is no word or page limit on these reports-the Court trusts counsel to keep these reports to a reasonable length. SO ORDERED by Magistrate Judge S. Kato Crews on 11/10/2022. Text Only Entry (skclc1)
November 9, 2022 Filing 58 NOTICE of Entry of Appearance by Nathan Andrew Schacht on behalf of Novartis Pharmaceuticals CorpAttorney Nathan Andrew Schacht added to party Novartis Pharmaceuticals Corp(pty:dft) (Schacht, Nathan)
November 4, 2022 Opinion or Order Filing 57 MINUTE ORDER denying without prejudice Defendant's #55 Joint Motion to Extend Scheduling Order Deadlines for failing to (1) establish excusable neglect in their request to extend the deadline for written discovery until after it expired. Fed. R. Civ. P. 6(b)(1)(B); see Birch v. Polaris Indus., Inc., 812 F.3d 1238, 1248 (10th Cir. 2015) (district court did not abuse its discretion in denying partys untimely motion for failing to establish excusable neglect and good cause); and (2) comply with the Courts D.C.Colo.CivR 6.1(b), and (c). The press of business does not establish good cause in this Court to amend a scheduling order. Any future motion for extension of time that is not in full compliance with all applicable Court rules and practice standards will be denied. Moreover, the Court previously warned the parties in its prior 40 Order that any future extensions of deadlines would only be granted for exceedingly good cause; that order is still in effect.SO ORDERED by Magistrate Judge S. Kato Crews on 11/4/2022. Text Only Entry (skclc2).
November 3, 2022 Opinion or Order Filing 56 MEMORANDUM regarding #55 Joint MOTION to Amend/Correct/Modify Scheduling Order filed by Novartis Pharmaceuticals Corp. Motion referred to Magistrate Judge S. Kato Crews by Senior Judge Christine M. Arguello on 11/3/2022. Text Only Entry (cmasec)
November 3, 2022 Filing 55 Joint MOTION to Amend/Correct/Modify Scheduling Order by Defendant Novartis Pharmaceuticals Corp. (Attachments: #1 Proposed Order (PDF Only))(McIntyre, Michael)
October 27, 2022 Filing 54 ANSWER to #53 Amended Complaint Third by Novartis Pharmaceuticals Corp.(McIntyre, Michael)
October 13, 2022 Filing 53 AMENDED COMPLAINT THIRD against Novartis Pharmaceuticals Corp, filed by Lauri Littlewood.(Harrington, John)
October 12, 2022 Opinion or Order Filing 52 MINUTE ORDER granting Plaintiff's [ 48 ] Third Motion for leave to Amend the Complaint following the Court's [ 47 ] Order. Defendant did not file a response (within 21 days) objecting to the current Motion under D.C.COLO.L.CivR 7.1(d), the Court, therefore, considers Plaintiff's Motion as unopposed. Plaintiff is ordered to file a clean copy of the amended pleading by tomorrow at the close of business.SO ORDERED by Magistrate Judge S. Kato Crews on 10/12/2022. Text Only Entry (skclc2).
September 29, 2022 Filing 51 NOTICE of Subpoena Duces Tecum by Defendant Novartis Pharmaceuticals Corp (McIntyre, Michael)
September 29, 2022 Filing 50 NOTICE of Subpoena Duces Tecum by Defendant Novartis Pharmaceuticals Corp (McIntyre, Michael)
September 2, 2022 Filing 49 MEMORANDUM regarding #48 MOTION for Leave to Amend filed by Lauri Littlewood. Motion referred to Magistrate Judge S. Kato Crews by Senior Judge Christine M. Arguello on 9/2/2022. Text Only Entry (cmasec)
September 2, 2022 Filing 48 MOTION for Leave to Amend by Plaintiff Lauri Littlewood. (Attachments: #1 Exhibit Exhibit 1, #2 Exhibit Exhibit 2, #3 Proposed Order (PDF Only))(Harrington, John)
August 3, 2022 Opinion or Order Filing 47 ORDER: Defendant's Partial Motion to Dismiss #34 is GRANTED. Plaintiff shall have thirty days from the date of this order to file a motion for leave to amend her complaint, together with a redlined copy of the Amended Complaint, otherwise her claims will be dismissed with prejudice. SO ORDERED by Judge Christine M. Arguello on 8/3/2022. (sphil, )
July 20, 2022 Opinion or Order Filing 46 ORDER granting #42 Motion to Withdraw as Attorney. The Court finds the requirements of D.C.COLO.LAttyR 5(b) have been met. Therefore, the Motion is GRANTED. IT IS ORDERED that Attorneys Steven M. Gutierrez and Austin Warren Jensen are TERMINATED as counsel for Defendant Novartis. The Court notes that Defendant continues to be represented by Michael McIntyre. IT IS FURTHER ORDERED that the Clerk of the Court shall cancel future ECF filing notifications to Steven M. Gutierrez and Austin Warren Jensen. SO ORDERED by Magistrate Judge S. Kato Crews on 7-20-2022. Text Only Entry (skclc2).
July 20, 2022 Opinion or Order Filing 45 ORDER granting #43 Motion for Extension of Time to File. Given new counsel, the Court will GRANT the unopposed Motion. Accordingly, Defendant's responses to written discovery are due 8-4-2022. SO ORDERED by Magistrate Judge S. Kato Crews on 7-20-2022. Text Only Entry (skclc2).
July 7, 2022 Filing 44 MEMORANDUM regarding #43 Unopposed MOTION for Extension of Time to Respond to Written Discovery filed by Novartis Pharmaceuticals Corp, #42 Unopposed MOTION to Withdraw as Attorney filed by Novartis Pharmaceuticals Corp. Motion referred to Magistrate Judge S. Kato Crews by Judge Christine M. Arguello on 7/7/2022. Text Only Entry (cmasec)
July 5, 2022 Filing 43 Unopposed MOTION for Extension of Time to Respond to Written Discovery by Defendant Novartis Pharmaceuticals Corp. (McIntyre, Michael)
July 5, 2022 Filing 42 Unopposed MOTION to Withdraw as Attorney by Defendant Novartis Pharmaceuticals Corp. (Attachments: #1 Proposed Order (PDF Only))(Gutierrez, Steven)
July 1, 2022 Filing 41 NOTICE of Entry of Appearance by Michael Scott McIntyre on behalf of Novartis Pharmaceuticals CorpAttorney Michael Scott McIntyre added to party Novartis Pharmaceuticals Corp(pty:dft) (McIntyre, Michael)
June 14, 2022 Opinion or Order Filing 40 ORDER granting #38 Motion for Extension of Time to File. The parties seek a 90-day extension of certain discovery dates, in part, because they are waiting on a ruling on Defendant's pending partial motion to dismiss. Instead of requesting this matter be stayed, the parties independently decided to slow the discovery process with the hopes a ruling would occur by July 1, 2022. Given its unopposed nature, the Court will GRANT the Motion. However, the parties are cautioned that any future extensions of deadlines will only be granted for exceedingly good cause. This means the parties should not wait until after July 1, 2022, before scheduling depositions and proceeding forward with this case. The Scheduling Order is amended as follows: Written discovery due 10-31-2022; Discovery due 11-29-2022; and Dispositive motions due 12-29-2022. IT IS FURTHE ORDERED that the Final Pretrial Conference set for 12-5-2022 is VACATED and reset for 3-6-2023 at 09:30 AM in Courtroom C201 before Magistrate Judge S. Kato Crews. SO ORDERED by Magistrate Judge S. Kato Crews on 6-14-2022. Text Only Entry (skclc2). Modified to correct discovery date on 6/15/2022 (csarr, ).
June 6, 2022 Filing 39 MEMORANDUM regarding #38 Joint MOTION for Extension of Time to Complete Discovery filed by Lauri Littlewood. Motion referred to Magistrate Judge S. Kato Crews by Judge Christine M. Arguello on 6/6/2022. Text Only Entry (cmasec)
June 2, 2022 Filing 38 Joint MOTION for Extension of Time to Complete Discovery by Plaintiff Lauri Littlewood. (Attachments: #1 Proposed Order (PDF Only))(Harrington, John)
April 15, 2022 Filing 37 Joint STATUS REPORT by Plaintiff Lauri Littlewood. (Harrington, John)
March 21, 2022 Filing 36 BRIEF in Support of #34 MOTION to Dismiss Plaintiff's Second Amended Complaint filed by Defendant Novartis Pharmaceuticals Corp. (Gutierrez, Steven)
March 7, 2022 Filing 35 BRIEF in Opposition to #34 MOTION to Dismiss Plaintiff's Second Amended Complaint filed by Plaintiff Lauri Littlewood. (Attachments: #1 Exhibit Exhibit A, #2 Exhibit Exhibit B, #3 Exhibit Exhibit C)(Harrington, John)
February 15, 2022 Filing 34 MOTION to Dismiss Plaintiff's Second Amended Complaint by Defendant Novartis Pharmaceuticals Corp. (Attachments: #1 Exhibit, #2 Exhibit)(Gutierrez, Steven)
February 15, 2022 Filing 33 ANSWER to #32 Amended Complaint by Novartis Pharmaceuticals Corp.(Gutierrez, Steven)
February 1, 2022 Filing 32 AMENDED COMPLAINT (SECOND) against Novartis Pharmaceuticals Corp, filed by Lauri Littlewood.(Harrington, John)
January 27, 2022 Opinion or Order Filing 31 ORDER by Judge Christine M. Arguello on 1/27/2022, re: #26 Plaintiff's Motion for Leave to Amend is GRANTED. ORDERED Plaintiff shall file a clean version of the Second Amended Complaint by February 2, 2022. ORDERED Defendant's Motion to Dismiss (Doc. # 17) is DENIED WITHOUTPREJUDICE; and the parties' Joint Motion to Stay Defendant's Reply in Support of Its Motion to Dismiss (Doc. # 30) is DENIED AS MOOT. (sphil, )
January 24, 2022 Filing 30 Joint MOTION to Stay re #17 MOTION to Dismiss by Defendant Novartis Pharmaceuticals Corp. (Gutierrez, Steven)
January 20, 2022 Opinion or Order Filing 29 SCHEDULING ORDER: by Magistrate Judge S. Kato Crews on 1/20/2022. (amont, )
January 20, 2022 Filing 28 COURTROOM MINUTES for proceedings held before Magistrate Judge S. Kato Crews: Telephone Scheduling Conference held on 1/20/2022. Discovery due by 8/31/2022. Dispositive Motions due by 9/30/2022. Joint Status Report due by 4/15/2022. Telephone Final Pretrial Conference set for 12/5/2022 10:00 AM in Courtroom C201 before Magistrate Judge S. Kato Crews. FTR: Courtroom C-201. (amont, )
January 18, 2022 Filing 27 BRIEF in Opposition to #17 MOTION to Dismiss filed by Plaintiff Lauri Littlewood. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Proposed Order (PDF Only))(Harrington, John)
January 18, 2022 Filing 26 MOTION to Amend/Correct/Modify #24 MOTION for Leave to Amend by Plaintiff Lauri Littlewood. (Attachments: #1 Exhibit 1: Proposed Second Amended Complaint, #2 Proposed Order (PDF Only))(Harrington, John)
January 18, 2022 Opinion or Order Filing 25 ORDER: Denying without prejudice #24 Motion for Leave to Amend for failure to comply with CMA Civ. Practice Standard 10.1(a). SO ORDERED by Judge Christine M. Arguello on 1/18/2022. Text Only Entry(cmasec)
January 18, 2022 Filing 24 MOTION for Leave to Amend by Plaintiff Lauri Littlewood. (Attachments: #1 Exhibit 1: Proposed Second Amended Complaint, #2 Proposed Order (PDF Only))(Harrington, John)
January 13, 2022 Opinion or Order Filing 23 ORDER granting #21 Motion for Protective Order. The Court GRANTS the Parties' Motion for Protective Order with the exceptions fully documented herein. Specifically, the Court has struck reference to "Confidential -- Attorney's Eyes Only" throughout. The Court requires a more particularized explanation to designate documents as "Confidential -- Attorney's Eye's Only. The Parties may seek such specific designation to the Court directly, if needed. Further, the Court modified Section 6(a) to include the respective parties. SO ORDERED by Magistrate Judge S. Kato Crews on 1-13-2021. (skclc2).
January 12, 2022 Opinion or Order Filing 22 MEMORANDUM regarding #21 Joint MOTION for Protective Order filed by Novartis Pharmaceuticals Corp. Motion referred to Magistrate Judge S. Kato Crews by Judge Christine M. Arguello on 1/12/2022. Text Only Entry (cmasec)
January 12, 2022 Filing 21 Joint MOTION for Protective Order by Defendant Novartis Pharmaceuticals Corp. (Attachments: #1 Proposed Document)(Gutierrez, Steven)
January 10, 2022 Filing 20 Proposed Scheduling Order Rule 26(f) Report by Plaintiff Lauri Littlewood. (Attachments: #1 Proposed Order (PDF Only))(Harrington, John)
December 29, 2021 Opinion or Order Filing 19 ORDER REFERRING CASE to Magistrate Judge S. Kato Crews. Magistrate Judge Crews is designated to conduct NDISPO proceedings pursuant to 28 U.S.C. 636(b)(1)(A) and (B) and Fed. R. Civ. P. 72(a) and (b). Court-sponsored alternative dispute resolution is governed by D.C.COLO.LCivR 16.6. The Magistrate Judge, at his/her discretion, may convene such early neutral evaluation and/or settlement conferences and direct related procedures as may facilitate resolution of this case without the necessity of a motion or prior authorization of the undersigned. SO ORDERED by Judge Christine M. Arguello on 12/29/2021. Text Only Entry (cmasec)
December 28, 2021 Filing 18 ANSWER to #6 Amended Complaint by Novartis Pharmaceuticals Corp.(Gutierrez, Steven)
December 28, 2021 Filing 17 MOTION to Dismiss by Defendant Novartis Pharmaceuticals Corp. (Attachments: #1 Exhibit A)(Gutierrez, Steven)
December 21, 2021 Filing 16 MEMORANDUM RETURNING CASE by Senior Judge Lewis T. Babcock on 12/21/2021. This case is randomly reassigned to Judge Christine M. Arguello and drawn to Magistrate Judge S. Kato Crews. All future pleadings should be designated as 21-cv-02559-CMA. (trvo, )
December 20, 2021 Filing 15 CASE REASSIGNED pursuant to #14 Consent to Jurisdiction of Magistrate Judge. All parties do not consent. This case is randomly reassigned to Judge Lewis T. Babcock and drawn to Magistrate Judge S. Kato Crews. All future pleadings should be designated as 21-cv-02559-LTB. (Text Only Entry) (csarr, )
December 20, 2021 Filing 14 CONSENT to Jurisdiction of Magistrate Judge by Defendant Novartis Pharmaceuticals Corp All parties do not consent.. (Gutierrez, Steven)
November 24, 2021 Filing 13 SUMMONS Returned Executed by Lauri Littlewood. Novartis Pharmaceuticals Corp served on 11/16/2021, answer due 12/28/2021. (Harrington, John)
November 22, 2021 Opinion or Order Filing 12 ORDER granting #11 Motion for Extension of Time to Answer or Otherwise Respond. In light of its unopposed nature, the Court finds good cause to GRANT the Motion. Accordingly, Defendant has up to, and including, 12-28-2021 to answer or otherwise respond. SO ORDERED by Magistrate Judge S. Kato Crews on 11-22-2021. Text Only Entry (skclc2).
November 19, 2021 Filing 11 Stipulated MOTION for Extension of Time to File Answer or Otherwise Respond re #6 Amended Complaint by Defendant Novartis Pharmaceuticals Corp. (Gutierrez, Steven)
November 19, 2021 Opinion or Order Filing 10 MINUTE ORDER Due to a conflict on the Court's calendar, the Telephonic Scheduling Conference set for 1-19-2022 is VACATED and RESET for 1-20-2022 at 10:00 am in Courtroom C201 before Magistrate Judge S. Kato Crews. Dial in instructions remain the same. SO ORDERED by Magistrate Judge S. Kato Crews on 11-19-2021. Text Only Entry (skclc2, )
November 19, 2021 Opinion or Order Filing 9 Setting Telephonic Rule 16(b) Scheduling Conference. The Telephonic Scheduling Conference is set for 1-19-2022 at 9:30 am in Courtroom C201 before Magistrate Judge S. Kato Crews. The parties shall file their proposed scheduling order, and email a copy in Word format to Crews_Chambers@cod.uscourts.gov, 7 days before the Telephonic Scheduling Conference (on or before 1-12-2022). The Magistrate Judge Consent Form [#3-1] is due 1-12-2022. Dial in information for the Scheduling Conference is as follows:CONFERENCE CALL LINE: (888) 251-2909ACCESS CODE: 5662814# SO ORDERED by Magistrate Judge S. Kato Crews on 11-19-2021. Text Only Entry (skclc2).
November 19, 2021 Filing 8 NOTICE of Entry of Appearance by Austin Warren Jensen on behalf of Novartis Pharmaceuticals CorpAttorney Austin Warren Jensen added to party Novartis Pharmaceuticals Corp(pty:dft) (Jensen, Austin)
November 19, 2021 Filing 7 NOTICE of Entry of Appearance by Steven M. Gutierrez on behalf of Novartis Pharmaceuticals CorpAttorney Steven M. Gutierrez added to party Novartis Pharmaceuticals Corp(pty:dft) (Gutierrez, Steven)
October 14, 2021 Filing 6 AMENDED COMPLAINT against Novartis Pharmaceuticals Corp, filed by Lauri Littlewood.(Oswald, Robert)
October 14, 2021 Filing 5 NOTICE of Filing Amended Pleading by Plaintiff Lauri Littlewood (Attachments: #1 Exhibit 1)(Oswald, Robert)
September 22, 2021 Filing 4 ADVISORY NOTICE OF NONCOMPLIANCE WITH COURT RULES/PROCEDURES:re: #1 Complaint, filed by attorneyR. Scott Oswald. DO NOT REFILE THE DOCUMENT. Action to take - counsel must submit a change of contact request through the Manage my Account tab at the PACER website at https://www.pacer.gov/, pursuant to D.C.COLO.LAttyR 5(c) and 3.5 of the Electronic Case Filing Procedures (Civil cases).(Text Only Entry) (jtorr, )
September 22, 2021 Filing 3 SUMMONS issued by Clerk. (Attachments: #1 Magistrate Judge Consent Form) (jtorr, )
September 21, 2021 Filing 2 Case assigned to Magistrate Judge S. Kato Crews. Text Only Entry (jtorr, )
September 21, 2021 Filing 1 COMPLAINT against Novartis Pharmaceuticals Corporation (Filing fee $ 402,Receipt Number ACODC-8085216)Attorney Robert Scott Oswald added to party Lauri Littlewood(pty:pla), filed by Lauri Littlewood. (Attachments: #1 Civil Cover Sheet, #2 Summons)(Oswald, Robert)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Colorado District Court's Electronic Court Filings (ECF) System

Search for this case: Littlewood v. Novartis Pharmaceuticals Corp
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Lauri Littlewood
Represented By: Robert Scott Oswald
Represented By: John Thomas Harrington, Jr.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Novartis Pharmaceuticals Corporation
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Novartis Pharmaceuticals Corp
Represented By: Austin Warren Jensen
Represented By: Steven M. Gutierrez
Represented By: Michael Scott McIntyre
Represented By: Nathan Andrew Schacht
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?